[1] 罗真真, 张震, 乔亚敏,等. 萝卜硫素对结直肠癌SW620细胞增殖、凋亡及迁移的影响[J]. 郑州大学学报:医学版, 2017, 52(3):281-284. [2] Li J, Mao X, Wang X, et al. miR-433 reduces cell viability and promotes cell apoptosis by regulating MACC1 in colorectal cancer[J]. Oncol Lett, 2017, 13(1):81-88. [3] 宋军民, 杨超, 常远, 等. miR-126在人结肠癌细胞中的表达及其对结肠癌细胞生物学行为的影响[J]. 中国老年学杂志, 2015, 35(6):1453-1455. [4] 杨泽波, 张媛媛, 陶开义,等. miR-381在食管癌组织中的表达及临床意义[J]. 河北医学, 2018(3):362-365. [5] Sun TY, Xie HJ, He H, et al. miR-26a inhibits the proliferation of ovarian cancer cells via regulating CDC6 expression[J]. Am J Transl Res, 2016, 8(2):1037-1046. [6] 王刚. miR-26介导EZH2调控肝癌细胞増殖及迁移的作用机制研究[D]. 济南:山东大学, 2015. [7] 林荣凯. miR-26及其靶基因HMGA1对膀胱癌的影响[D]. 重庆:第三军医大学, 2015. [8] Akhter MZ, Rajeswari MR. Triplex forming oligonucleotides targeted to hmga1 selectively inhibit its expression and induce apoptosis in human cervical cancer[J].J Biomol Struct Dyn, 2017, 35(4):689-703. [9] 崔瑞新, 吕风华, 岳莹,等. microRNA-499靶控的PI3 K/Akt通路在大鼠缺血-再灌注心肌损伤中的作用[J]. 郑州大学学报:医学版, 2016, 51(6):740-743. [10] Svoronos AA, Engelman DM, Slack FJ. OncomiR or tumor suppressor? The duplicity of microRNAs in cancer[J]. Cancer Res, 2016, 76(13):3666-3670. [11] Paladini L, Fabris L, Bottai G, et al. Targeting microRNAs as key modulators of tumor immune response[J]. J Exp Clin Cancer Res, 2016, 35:103. [12] 邵青, 刘月, 宁守斌, 等. MiR-26a诱导人肝癌细胞凋亡的机制[J]. 华南国防医学杂志, 2015(10):725-729. [13] Fkih Mhamed I, Privat M, Trimeche M, et al. miR-10b, miR-26a, miR-146a And miR-153 expression in triple negative vs non triple negative breast cancer:potential biomarkers[J]. Pathol Oncol Res, 2017, 23(4):1-13. [14] 林高阳. miR-26a靶向GSK-3β调控β-catenin信号通路增强肺癌细胞转移潜能的机制研究[D].天津:天津医科大学, 2015. [15] Chandra V, Kim JJ, Mittal B, et al. MicroRNA aberrations:An emerging field for gallbladder cancer management[J]. World J Gastroenterol, 2016, 22(5):1787-1799. [16] Li J, An G, Zhang M, et al. Long non-coding RNA TUG1 acts as a miR-26a sponge in human glioma cells[J]. Biochem Biophys Res Commun, 2016, 477(4):743-748. [17] Sepe R, Piscuoglio S, Quintavalle C, et al. HMGA1 overexpression is associated with a particular subset of human breast carcinomas[J]. J Clin Pathol, 2016, 69(2):117-121. [18] Cheng Y, Yang X, Deng X, et al. MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1[J]. Tumour Biol, 2015, 36(10):8015-8023. [19] Huang FY, Wong DK, Seto WK, et al. Estradiol induces apoptosis via activation of miRNA-23a and p53:implication for gender difference in liver cancer development[J]. Oncotarget, 2015, 6(33):34941. [20] Guzman N, Agarwal K, Asthagiri D, et al. Breast cancer-specific miR signature unique to extracellular vesicles includes "microrna-like" tRNA fragments[J]. Mol Cancer Res, 2015, 13(5):891-901. [21] Esposito F, De Martino M, D'Angelo D, et al. HMGA1-pseudogene expression is induced in human pituitary tumors[J]. Cell Cycle, 2015, 14(9):1471-1475. [22] Kitchen MO, Yacqub-Usman K, Emes RD, et al. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells[J]. Pituitary, 2015, 18(5):674-684. [23] Zhai H, Sui M, Jiang L, et al. MiR-296 promotes colorectal cancer cells growth through regulating NF-κB[J]. Int J clinexppath, 2016, 9(4):4391-4396. [24] Borges NM, do Vale Elias M, Fook-Alves VL, et al. Angiomirs expression profiling in diffuse large B-Cell lymphoma[J]. Oncotarget, 2016, 7(4):4806-4816. [25] Zhong Y, Yao G, Zhao G, et al. miR-26a suppresses the growth and metastasis via targeting matrix metalloproteinase 14 in pancreatic ductal adenocarcinoma[J]. Int J Clinexppath, 2016, 9(4):4803-4809. [26] 张玲,屈亚威,谈涛,等.高分辨率显微内镜对结肠癌诊断价值的初步研究[J].解放军医学杂志,2016,41(9):746-749. [27] 王蓓,林玲.家族性高胆固醇血症临床表型及其与基因型关系[J].中国实用内科杂志,2016,36(6):508-511. |